US Edition
Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs
Summary by aboutlawsuits.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs
Oxbryta was recalled in September 2024, following multiple reports of injuries and deaths. A New Jersey man has filed a lawsuit, which claims that he suffered multiple injuries and hospitalizations due to what he, and federal regulators, say was the defective nature of the sickle cell disease drug, Oxbryta. The complaint (PDF) was brought by Maurice Fraizier …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
